Manuel Montero Gómez de las Heras

Dr. Manuel Montero Gómez de las Heras

Centro de Biología Molecular Severo Ochoa
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2020 in The FEBS Journal
Verified
Journal Article
Open access
GSGonzalo Soto‐Heredero
Gonzalo Soto‐Heredero
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
EREnrique Gabandé Rodríguez
Enrique Gabandé Rodríguez
JOJorge Oller
Jorge Oller
MMMaria Mittelbrunn
Maria Mittelbrunn
The inflammatory response involves the activation of several cell types to fight insults caused by a plethora of agents, and to maintain the tissue homoeostasis. On the one hand, cells involved in the pro‐inflammatory response, such as inflammatory M1 macrophages, Th1 and Th17 lymphocytes or activated microglia, must rapidly provide energy to fuel inflammation, which is essentially accomplished by glycolysis and high lactate production. On the other hand, regulatory T cells or M2 macrophages, which are involved in immune regulation and resolution of inflammation, preferentially use fatty acid oxidation through the TCA cycle as a main source for energy production. Here, we discuss the impact of glycolytic metabolism at the different steps of the inflammatory response. Finally, we review a wide variety of molecular mechanisms which could explain the relationship between glycolytic metabolites and the pro‐inflammatory phenotype, including signalling events, epigenetic remodelling, post‐transcriptional regulation and post‐translational modifications. Inflammatory processes are a common feature of many age‐associated diseases, such as cardiovascular and neurodegenerative disorders. The finding that immunometabolism could be a master regulator of inflammation broadens the avenue for treating inflammation‐related pathologies through the manipulation of the vascular and immune cell metabolism.

7 June 2021 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
Elisa CarrascoElisa Carrasco
Elisa Carrasco
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
EGEnrique Gabandé-Rodríguez
Enrique Gabandé-Rodríguez
GDGabriela Desdín-Micó
Gabriela Desdín-Micó
JAJuan Francisco Aranda
Juan Francisco Aranda
MMMaria Mittelbrunn
Maria Mittelbrunn

28 December 2019 in Cells
Verified
Journal Article
Open access
PDF file
EREnrique Gabandé Rodríguez
Enrique Gabandé Rodríguez
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
MMMaria Mittelbrunn
Maria Mittelbrunn
Mitochondrial metabolism and autophagy are two of the most metabolically active cellular processes, playing a crucial role in regulating organism longevity. In fact, both mitochondrial dysfunction or autophagy decline compromise cellular homeostasis and induce inflammation. Calorie restriction (CR) is the oldest strategy known to promote healthspan, and a plethora of CR mimetics have been used to emulate its beneficial effects. Herein, we discuss how CR and CR mimetics, by modulating mitochondrial metabolism or autophagic flux, prevent inflammatory processes, protect the intestinal barrier function, and dampen both inflammaging and neuroinflammation. We outline the effects of some compounds classically known as modulators of autophagy and mitochondrial function, such as NAD+ precursors, metformin, spermidine, rapamycin, and resveratrol, on the control of the inflammatory cascade and how these anti-inflammatory properties could be involved in their ability to increase resilience to age-associated diseases.

12 May 2021 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
MNMaria N Navarro
Maria N Navarro
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
MMMaria Mittelbrunn
Maria Mittelbrunn
Metabolism is dynamically regulated to accompany immune cell function, and altered immunometabolism can result in impaired immune responses. Concomitantly, the pharmacological manipulation of metabolic processes offers an opportunity for therapeutic intervention in inflammatory disorders. The nicotinamide adenine dinucleotide (NAD+) is a critical metabolic intermediate that serves as enzyme cofactor in redox reactions, and is also used as a co‐substrate by many enzymes such as sirtuins, adenosine diphosphate ribose transferases and synthases. Through these activities, NAD+ metabolism regulates a broad spectrum of cellular functions such as energy metabolism, DNA repair, regulation of the epigenetic landscape and inflammation. Thus, the manipulation of NAD+ availability using pharmacological compounds such as NAD+ precursors can have immune‐modulatory properties in inflammation. Here, we discuss how the NAD+ metabolism contributes to the immune response and inflammatory conditions, with a special focus on multiple sclerosis, inflammatory bowel diseases and inflammageing.LINKED ARTICLES: This article is part of a themed issue on Inflammation, Repair and Ageing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.9/issuetoc

30 April 2025 in Nature Aging
Verified
Journal Article
Open access
PDF file
GSGonzalo Soto-Heredero
Gonzalo Soto-Heredero
EREnrique Gabandé Rodríguez
Enrique Gabandé Rodríguez
Elisa CarrascoElisa Carrasco
Elisa Carrasco
JEJosé Ignacio Escrig-Larena
José Ignacio Escrig-Larena
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
MMMaria Mittelbrunn
Maria Mittelbrunn
Recent studies using single-cell RNA sequencing technology have uncovered several subpopulations of CD4+ T cells that accumulate with aging. These age-associated T cells are emerging as relevant players in the onset of inflammaging and tissue senescence. Here, based on information provided by single-cell RNA sequencing data, we present a flow cytometry panel that allows the identification of age-associated T cell subsets in systematic larger analysis in mice. We use this panel to evaluate at the single-cell level mitochondrial and senescence marks in the different age-associated CD4+ T cell subpopulations. Our analysis identifies a subpopulation of regulatory T (Treg) cells that is characterized by the extracellular expression of the co-inhibitory molecule killer cell lectin-like receptor subfamily G member 1 (KLRG1) and accumulates with aging in humans and mice. KLRG1-expressing Treg cells display senescence features such as mitochondrial alterations, increased expression of cell-cycle regulators and genomic DNA damage. Functionally, KLRG1+ Treg cells show a reduced suppressive activity in vivo accompanied by a pro-inflammatory phenotype.

1 August 2025 in Science Immunology
Verified
Journal Article
Open access
MHManuel Montero Gómez de las Heras
Manuel Montero Gómez de las Heras
Elisa CarrascoElisa Carrasco
Elisa Carrasco
MPMario Pérez-Manrique
Mario Pérez-Manrique
NINaohiro Inohara
Naohiro Inohara
SDSandra Delgado-Pulido
Sandra Delgado-Pulido
MMMaria Mittelbrunn
Maria Mittelbrunn
Healthy aging relies on a symbiotic host-microbiota relationship. The age-associated decline of the immune system can pose a threat to this delicate equilibrium. In this work, we investigated how the functional deterioration of T cells can affect host-microbiota symbiosis and gut barrier integrity and the implications of this deterioration for inflammaging, senescence, and health decline. Using the Tfam fl/fl Cd4 Cre mouse model, we found that T cell failure compromised gut immunity leading to a decrease in T follicular cells and regulatory T cells (T reg cells) and an accumulation of highly proinflammatory and cytotoxic T cells. These alterations were associated with intestinal barrier disruption and gut dysbiosis. Microbiota depletion or adoptive transfer of total CD4 T cells or a T reg cell–enriched pool prevented gut barrier dysfunction and mitigated premature inflammaging and senescence, ultimately enhancing the health span in this mouse model. Thus, a competent CD4 T cell compartment is critical to ensure healthier aging by promoting host-microbiota mutualism and gut barrier integrity.